“…This technology combines fluorescent‐dyed microspheres, a detection instrument based on lasers read‐out, digital signal processing and an analysis software (Christopher‐Hennings et al., 2013; Graham et al., 2019). While BBMAs are widely applied in human health, with the development of methods for drug discovery (Komnatnyy et al., 2018), diseases diagnosis (Grignard et al., 2019; Lu et al., 2005) and immune response characterisation (Jones et al., 2002) among others, work in the veterinary field has been more limited, although interest has been rising recently (Chen et al., 2016; Fabian et al., 2020; Hoste et al., 2020; Laamiri et al., 2016; Ragan et al., 2018). To date, there are a few commercial assays available (References TRD‐500 and TRD‐502, Biovet Inc. Saint‐Hyacinthe, Canada).…”